Erik Ingelsson
Vermögen: 578 145 $ am 31.05.2026
Vermögen: 578 145 $ am 31.05.2026
Erik Ingelsson currently works at Wave Life Sciences Ltd., as Chief Scientific Officer from 2024.
Dr. Ingelsson also formerly worked at GSK Plc, as Senior Vice President & Head-Target Discovery and Stanford University, as Professor-Medicine from 2015 to 2019.
Dr. Ingelsson received his doctorate degree from the University of Uppsala.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.04.2026 | 87’864 ( 0.05% ) | 578 145 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Technik-/Wissenschafts-/F&E-Leiter | 09.05.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2019 |
| GSK PLC | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Wave Life Sciences Ltd.
Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen